Vertex Pharmaceuticals Inc
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Income before provision for income taxes — Total by Quarter
Income before provision for income taxes — Total ($M) ($M)
Vertex Pharmaceuticals Income before provision for income taxes — Total: $1,392M in Q2 2026, up 8.5% from a year earlier. That is the highest of the 65 quarters on record here.
Latest, Q2 2026
1,392
Period ended Jun 30, 2026
Change on a year earlier
+8.5%
1,283 in Q2 2025
History
65 quarters
Since Q2 2010
Sources
50
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-K Note (Income Taxes).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Income before provision for income taxes — Total ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,392 | +8.5% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,253 | +71.5% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,331 | +17.1% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,299 | +6.1% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,283 | -137.8% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 31, 2025 | 730 | -42.9% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,137 | -1.0% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,224 | +3.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | -3,391 | -392.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,279 | +43.5% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,148 | +6.6% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,179 | +0.2% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,162 | +13.4% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 892 | -6.6% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,077 | +23.6% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,176 | +8.6% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,024 | -2,417.6% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 955 | +16.3% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2021 | Dec 31, 2021 | 871 | -2.0% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,083 | +45.2% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2021 | Jun 30, 2021 | -44.2 | -105.4% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 821 | +24.9% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 889 | +31.3% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2020 | Sep 30, 2020 | 746 | +955.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 825 | +152.2% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 658 | +105.3% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 677 | +1,982.8% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2019 | Sep 30, 2019 | 70.7 | -48.2% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 327 | +51.0% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | 320 | +49.2% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 32.5 | -71.1% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 137 | -132.7% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 217 | +510.1% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | 215 | -15.3% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 112 | +453.7% | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2017 | Sep 30, 2017 | -417 | +969.7% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2017 | Jun 30, 2017 | 35.5 | -297.2% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 254 | -928.4% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2016 | Dec 31, 2016 | 20.3 | -126.7% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Sep 30, 2016 | -39 | -57.8% | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2016 | Jun 30, 2016 | -18 | -90.6% | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2016 | Mar 31, 2016 | -30.6 | -84.6% | Form 10-Q (filed 2016-05-03) ↗ |
| Q4 2015 | Dec 31, 2015 | -76 | -57.4% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | -92.5 | -44.5% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -191 | +20.5% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | -198 | -14.2% | Form 10-Q (filed 2015-05-04) ↗ |
| Q4 2014 | Dec 31, 2014 | -179 | +811.2% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2014 | Sep 30, 2014 | -167 | +40.1% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | -158 | +194.4% | Form 10-K (filed 2015-02-13) ↗ |
| Q1 2014 | Mar 31, 2014 | -231 | -46.7% | Form 10-K (filed 2015-02-13) ↗ |
| Q4 2013 | Dec 31, 2013 | -19.6 | -75.7% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2013 | Sep 30, 2013 | -119 | +2,231.4% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2013 | Jun 30, 2013 | -53.8 | +273.6% | Form 10-K (filed 2015-02-13) ↗ |
| Q1 2013 | Mar 31, 2013 | -434 | -593.5% | Form 10-K (filed 2015-02-13) ↗ |
| Q4 2012 | Dec 31, 2012 | -80.8 | -138.3% | Form 10-K (filed 2013-03-01) ↗ |
| Q3 2012 | Sep 30, 2012 | -5.10 | -102.5% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | -14.4 | -91.8% | Form 10-Q (filed 2012-08-08) ↗ |
| Q1 2012 | Mar 31, 2012 | 87.9 | -149.9% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 211 | -216.9% | Form 10-K (filed 2012-02-22) ↗ |
| Q3 2011 | Sep 30, 2011 | 201 | -196.0% | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2011 | Jun 30, 2011 | -175 | -12.5% | Form 10-Q (filed 2011-08-09) ↗ |
| Q1 2011 | Mar 31, 2011 | -176 | – | Form 10-K (filed 2012-02-22) ↗ |
| Q4 2010 | Dec 31, 2010 | -180 | – | Form 10-Q (filed 2011-11-03) ↗ |
| Q3 2010 | Sep 30, 2010 | -209 | – | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2010 | Jun 30, 2010 | -200 | – | Form 10-Q (filed 2011-08-09) ↗ |
Breakdown
What makes up income before provision for income taxes — Total
Cite this data
StockData. (2026). Vertex Pharmaceuticals Income before provision for income taxes — Total ($M), quarterly Q2 2010–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/pretax-tot
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.